Quantitative imaging support for clinical trials. PhenoMx contributes to and accelerates the development of pharma and biotech therapeutics, by providing strategic imaging analysis.
Camurus AB (Accelsiors CRO) - A Phase 3, multi-center, randomized, double-blind, placebo-controlled trial to assess efficacy, pharmacokinetics and safety of CAM2029 (octreotide subcutaneous depot) in patients with acromegaly
Interested in adding quantitative imaging to your upcoming clinical trial? Contact PhenoMx to speak further. We'd love to hear from you.